{"pmid":32343152,"title":"ABO blood group predisposes to COVID-19 severity and cardiovascular diseases.","text":["ABO blood group predisposes to COVID-19 severity and cardiovascular diseases.","Eur J Prev Cardiol","Dai, Xiaofeng","32343152"],"journal":"Eur J Prev Cardiol","authors":["Dai, Xiaofeng"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32343152","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1177/2047487320922370","topics":["Treatment","Mechanism","Diagnosis"],"weight":1,"_version_":1666138495108775937,"score":9.490897,"similar":[{"pmid":32379894,"title":"Association between ABO blood groups and risk of SARS-CoV-2 pneumonia.","text":["Association between ABO blood groups and risk of SARS-CoV-2 pneumonia.","In December, 2019, a cluster of acute respiratory illness caused by a novel coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), occurred in Wuhan, China.(1,2) Epidemiological, clinical characteristics, risk factors for mortality of patients infected with SARS-CoV-2, and risk factors in the susceptibility to SARS-CoV-2 included age and chronic disease have been reported.","Br J Haematol","Li, Juyi","Wang, Xiufang","Chen, Jian","Cai, Yi","Deng, Aiping","Yang, Ming","32379894"],"abstract":["In December, 2019, a cluster of acute respiratory illness caused by a novel coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), occurred in Wuhan, China.(1,2) Epidemiological, clinical characteristics, risk factors for mortality of patients infected with SARS-CoV-2, and risk factors in the susceptibility to SARS-CoV-2 included age and chronic disease have been reported."],"journal":"Br J Haematol","authors":["Li, Juyi","Wang, Xiufang","Chen, Jian","Cai, Yi","Deng, Aiping","Yang, Ming"],"date":"2020-05-08T11:00:00Z","year":2020,"_id":"32379894","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1111/bjh.16797","keywords":["abo blood groups","sars-cov-2","infection","markers","pneumonia"],"locations":["Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment","Mechanism","Diagnosis"],"weight":1,"_version_":1666597097271459840,"score":82.00592},{"pmid":32453863,"title":"COVID-19 & ABO blood group: another viewpoint.","text":["COVID-19 & ABO blood group: another viewpoint.","Juyi Li et al. [1] have recently published \"an association between ABO blood groups and risk of SARS-CoV-2 pneumonia\", an observation already reported a few weeks ago as a MedRxiv preprint by Jiao Zhao et al. [2] and which had a certain impact in the press.","Br J Haematol","Gerard, Christiane","Maggipinto, Gianni","Minon, Jean-Marc","32453863"],"abstract":["Juyi Li et al. [1] have recently published \"an association between ABO blood groups and risk of SARS-CoV-2 pneumonia\", an observation already reported a few weeks ago as a MedRxiv preprint by Jiao Zhao et al. [2] and which had a certain impact in the press."],"journal":"Br J Haematol","authors":["Gerard, Christiane","Maggipinto, Gianni","Minon, Jean-Marc"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32453863","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1111/bjh.16884","topics":["Mechanism"],"weight":1,"_version_":1667881798466535424,"score":78.34458},{"pmid":32420611,"title":"More on \"Association between ABO blood groups and risk of SARS-CoV-2 Pneumonia\".","text":["More on \"Association between ABO blood groups and risk of SARS-CoV-2 Pneumonia\".","We read with interest the recent report from Li and colleagues describing an association between ABO blood groups and risk of SARS-CoV-2 pneumonia [1]. In an initial study of 265 patients with COVID, the authors observed that blood group O individuals were significantly under-represented amongst patients who required hospitalization for severe COVID-19 infection (p < 0.01). Conversely, blood group A was significantly more common in patients with severe COVID-19 compared to the local population (p=0.017). Subsequently, in a larger validation cohort that included 2153 patients with COVID-19, this ABO effect was reproduced with blood group O again being associated with a significant protective effect (p < 0.001). In keeping with these data, another independent study (n=2173) also reported that blood group O was associated with reduced susceptibility to severe COVID-19.","Br J Haematol","O'Sullivan, Jamie M","Ward, Soracha","Fogarty, Helen","O'Donnell, James S","32420611"],"abstract":["We read with interest the recent report from Li and colleagues describing an association between ABO blood groups and risk of SARS-CoV-2 pneumonia [1]. In an initial study of 265 patients with COVID, the authors observed that blood group O individuals were significantly under-represented amongst patients who required hospitalization for severe COVID-19 infection (p < 0.01). Conversely, blood group A was significantly more common in patients with severe COVID-19 compared to the local population (p=0.017). Subsequently, in a larger validation cohort that included 2153 patients with COVID-19, this ABO effect was reproduced with blood group O again being associated with a significant protective effect (p < 0.001). In keeping with these data, another independent study (n=2173) also reported that blood group O was associated with reduced susceptibility to severe COVID-19."],"journal":"Br J Haematol","authors":["O'Sullivan, Jamie M","Ward, Soracha","Fogarty, Helen","O'Donnell, James S"],"date":"2020-05-19T11:00:00Z","year":2020,"_id":"32420611","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1111/bjh.16845","weight":0,"_version_":1667254896747872256,"score":57.994225},{"pmid":32387334,"title":"The Forrest Gump approach to preventing severe COVID-19 - reverse the predisposing pro-inflammatory state with exercise.","text":["The Forrest Gump approach to preventing severe COVID-19 - reverse the predisposing pro-inflammatory state with exercise.","Microbes Infect","Kenyon, Chris","32387334"],"journal":"Microbes Infect","authors":["Kenyon, Chris"],"date":"2020-05-11T11:00:00Z","year":2020,"_id":"32387334","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.micinf.2020.05.003","topics":["Mechanism","Treatment"],"weight":1,"_version_":1666428892660891648,"score":44.654953},{"pmid":32220633,"title":"Could Sars-coronavirus-2 trigger autoimmune and/or autoinflammatory mechanisms in genetically predisposed subjects?","text":["Could Sars-coronavirus-2 trigger autoimmune and/or autoinflammatory mechanisms in genetically predisposed subjects?","Autoimmun Rev","Caso, Francesco","Costa, Luisa","Ruscitti, Piero","Navarini, Luca","Del Puente, Antonio","Giacomelli, Roberto","Scarpa, Raffaele","32220633"],"journal":"Autoimmun Rev","authors":["Caso, Francesco","Costa, Luisa","Ruscitti, Piero","Navarini, Luca","Del Puente, Antonio","Giacomelli, Roberto","Scarpa, Raffaele"],"date":"2020-03-30T11:00:00Z","year":2020,"_id":"32220633","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.1016/j.autrev.2020.102524","topics":["Mechanism","Treatment"],"weight":1,"_version_":1666138490467778560,"score":43.493603}]}